StockWatch
·
Filing
Q4

Meghmani Organics Ltd

MOLFY2614 May 2026
Revenue-6.8%
Net Profit+327.6%
OPM4.16%

P&L

Quarterly Consolidated

Revenue
-6.8%474.34
Expenditure
-2.8%504.43
Net Profit
+327.6%8.03
NPM 1.57%+334.3%EPS ₹0.32+128.6%

vs Q3 FY26

Meghmani Organics Q4 FY26: Revenue Down 9%, Net Profit Down 42%

14 May 2026 · 14 May, 5:02 pm

Summary

Meghmani Organics Limited reported mixed financial results for FY26, with full-year revenue growing by 4% to ₹2,091.8 crore and net profit surging 89% to ₹125.3 crore. However, the fourth quarter witnessed a challenging environment, with revenue declining 9% year-on-year to ₹456.6 crore and net profit dropping 42% to ₹19.5 crore, largely due to subdued demand, rising input costs, and macroeconomic uncertainties. Mr. Ankit Patel, Chairman & Managing Director, acknowledged the positive start to the year but noted pressure on export volumes and margins in the latter half, while highlighting the addition of new nano fertilizer products and the temporary suspension of TiO2 operations.

Key Highlights

  1. 1

    Meghmani Organics Limited (MOL) reported a 4% year-on-year increase in revenue from operations to ₹2,091.8 crore for the financial year ended March 31, 2026.

  2. 2

    For FY26, EBITDA grew by 27% year-on-year, reaching ₹228.7 crore, while Net Profit saw a significant 89% increase to ₹125.3 crore.

  3. 3

    In Q4 FY26, revenue from operations declined by 9% year-on-year to ₹456.6 crore, impacted by subdued demand and macroeconomic uncertainties.

  4. 4

    Q4 FY26 also saw a substantial drop in profitability, with EBITDA falling by 59% to ₹26.2 crore and Net Profit decreasing by 42% to ₹19.5 crore.

  5. 5

    The Crop Protection segment constituted approximately 78% of the overall company’s revenue in FY26, reporting ₹1,631.2 crore in revenue with an EBITDA margin of 14.9%.

  6. 6

    The company strengthened its Crop Nutrition product portfolio by adding three new nano fertilizer products (Nano DAP, Nano NPK, and Nano Zinc), leveraging existing infrastructure at its Sanand facility.

  7. 7

    Operations in the Titanium Dioxide (TiO2) segment have been temporarily suspended due to commercial unviability stemming from elevated raw material costs and weaker price realisations.

Management Comments

M

Mr. Ankit Patel

The financial year began on a positive note with overall demand improving gradually. However, from the second half of FY26, export volumes came under pressure due to subdued demand amid macroeconomic uncertainties including US tariff and geopolitical headwinds. These external factors also led to higher input costs, while realisation remained broadly stable placing pressure on margins and profitability. In our Crop Nutrition segment, we have further strengthened our product portfolio with the addition of three new nano fertilizer products namely Nano DAP, Nano NPK and Nano Zinc. We will be manufacturing these products at our Sanand manufacturing facility in Gujarat, leveraging our existing infrastructure with no additional capital expenditure. In Titanium Dioxide (TiO2), operations have been temporarily suspended due to commercial unviability arising from elevated raw material costs and weaker price realisations following the withdrawal of anti-dumping duty (ADD).

Informational and educational content only. Not investment advice.